Patent Yard Sign in
Canadian application, no grantCanada

Protein kinases and uses thereof

CA 2265441 A1 · Owner: The University Of Kentucky Research Foundation · Inventors: Lusso, Marcos Fernando Godoy; Chappell, Joseph

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Nucleic acid molecules are disclosed that are induced upon pathogen invasion or elicitor treatment. Such molecules are functional in plants plant tissue , and in plant cells for inducible gene expression and altering the disease resistance phenotype of plants. Such molecules are or are related to, sequences of calcium dependent protein kinase genes. Also disclosed are methods for obtaining transgenic plants containing such nucleic acid molecules and methods for using such molecules. Polypeptides encoded by such nucleic acids are also disclosed herein.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed July 7, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 7, 2018.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 7, 2020.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 7, 1998
GrantedNo grant recorded
Term endedJuly 7, 2018
Patent numberCA 2265441 A1
Classification (IPC)C12N15/54 +2 more

Timeline

Timeline From CIPO dates

1999200120032005200720092011201320152017Application filedJuly 7, 1998Term endedJuly 7, 2018

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.